Research Coordinator Support Services for NHLBI Novel Structural Heart Intervention Protocols
Closed Special Notice Posted
- Solicitation number
- 75N98026Q00751
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Heart, Lung, and Blood Institute (NHLBI) is conducting a sole-source acquisition for Research Coordinator Support Services for NHLBI Novel Structural Heart Intervention Protocols, with proposals due July 30, 2026 at 3:00 PM EST. This is a noncompetitive, single-award procurement restricted to Emory University, conducted under FAR Part 13 and not expected to exceed the simplified acquisition threshold. The award period runs September 22, 2026 through September 21, 2027.
NHLBI determined sole-source award to Emory based on the institution's exclusive expertise in performing the investigational VINTAGE procedure and co-creation of the SESAME procedure. Transfer of this work to another institution would disrupt NHLBI's clinical trial network and is not feasible. Additionally, Emory University's IRB requirements mandate that research coordinators be university employees for sponsored trials.
Interested parties must submit responses including unit price, list price, shipping and handling costs, delivery period, prompt payment discount terms, F.O.B. point, DUNS number, TIN, and business size certification. All offerors are required to maintain active SAM registration. The NAICS code is 561990 with a small business size standard of $16.5 million. The contracting office is located at the Office of the Director, National Institutes of Health in Bethesda, Maryland, with John Lear and Andrew Dinh as primary contacts.
Notice text
See attached Notice of Intent for additional details.
Files
| File | Type | Posted |
|---|---|---|
| SoleSource Synopsis_75N98026Q00751.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| NOI - Acquisition of orthopedic procedure for NHLB | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - A Non-Invasive Prognostic Biomarker | Office of Logisitics and Acquisition Operations | No set-aside | |
| Strong Heart Study (SHS) Renewal - Coordinating Center (CC) | National Heart Lung and Blood Institute | No set-aside | |
| Strong Heart Study (SHS) - Legacy Cohort FC | National Heart Lung and Blood Institute | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity